Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor ...

The researcher has given an overview on the regulatory network of extracellular circRNAs in cancer and their impact on cancer drug resistance. In order to propagate malignancy, circRNAs shuttle ...

In addition, few cell-surface markers are completely cancer-specific, leading to side effects when antibodies attack healthy cells. Patrys, a Melbourne-based biotech company, is overcoming these ...

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and deadly forms of cancer. This means it grows and ...

Flow Cytometry: This test analyzes the physical and chemical properties of cells in a sample of blood or bone marrow. It ...

The process begins when cancer cells release protein fragments ... and quantified immune cell types based on specific markers on their surface. "We were very interested when we noticed lots ...

Ashfaq Marghoob provides skin cancer ... squamous cell carcinoma develops from a precancer called actinic keratosis, or solar keratosis (usually a rough, flat, pink spot on the skin, which may become ...

Dr. Tykodi is developing a new cellular immunotherapy for kidney cancer aimed at a marker called 5T4, which is found on the surface of almost all kidney cancer cells and only rarely on healthy adult ...

(RTTNews) - Immuno-oncology company Marker Therapeutics ... antigen (multiTAA)-specific T cell product, in patients with metastatic pancreatic cancer. The Company's lead asset, MT-601, is ...

A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse -- where ...